← k3vl4r
Log inGet started →

NBIX Price Forecast

AI-generated price forecast for NBIX across 1-hour, 4-hour, daily and weekly horizons — updated continuously, with a public accuracy track record.

As of July 2026: K3vl4r's AI model currently reads NBIX as 4/4 bearish · strong across its horizons (0 of 4 timeframes pointing up), with a last price of 178.00. See our public, auditable track record →

📈 Daily Top Picks beating the S&P 500 since launch→✓ Public, verifiable track record Live system status

Last price

178.00

AI outlook

4/4 bearish · STRONG

Timeframes up

0 / 4

Share𝕏 Post✈ Telegram

NBIX forecast by horizon

HorizonDirectionProjected move (end of horizon)Bullish prob.
1-hour~3 weeks out▼ Down-11.27%—
4-hour~3 months out▼ Down-18.56%—
Daily~6 months out▼ Down-25.69%—
Weekly~2 years out▼ Down-29.01%—

Latest NBIX news

From the market-news feed the forecasts are read against.

  • Neurocrine Biosciences Inc (NASDAQ:NBIX) Shines in the "Little Book That Makes You Rich" Screen · ChartMill · Jul 4
  • Neurocrine Biosciences: Why I Am Upholding A Buy Rating After M&A Deal For Soleno · SeekingAlpha · Jul 2
  • Neurocrine (NBIX) Reports Clinically Meaningful Benefits in 94% of Patients Treated for Tardive Dyskinesia · Insider Monkey · Jul 1
  • Neurocrine Biosciences Initiates Phase 2 Study of Crinecerfont in Pediatric Patients Under 4 Years Old with Classic Congenital Adrenal Hyperplasia · Yahoo · Jul 1
  • Neurocrine Biosciences Initiates Phase 2 Clinical Study To Assess Crinecerfont In Children Aged 3 Months To Under 4 Years With Classic Congenital Adrenal Hyperplasia · Benzinga · Jul 1

🔒

See the full NBIX forecast

Interactive forecast chart, price targets, and Monte-Carlo confidence bands — plus the daily AI Top Picks book. Free to start, no card required.

Create a free account →

Already have one? Log in

NBIX forecast — frequently asked

Will NBIX go up?

K3vl4r's AI model currently reads NBIX as 4/4 bearish · STRONG — 0 of 4 forecast horizons point up, so the overall read is leaning to the downside. This is a model-generated forecast for information only — not investment advice, and forecasts may be inaccurate.

What is the NBIX price prediction for 2026?

K3vl4r's model projects NBIX toward $174.02 over the next ~3 weeks, a -0.1% move from $174.22. Projections update continuously as new data arrives and are inherently uncertain. This is a model-generated forecast for information only — not investment advice, and forecasts may be inaccurate.

What price could NBIX reach?

Over its longest horizon (~~2 years), the model's projected target for NBIX is $173.75 (-0.3% vs $174.26). Confidence decreases the further out the horizon, so treat longer-range targets as one scenario, not a guarantee. This is a model-generated forecast for information only — not investment advice, and forecasts may be inaccurate.

Part of Biotech & Pharma forecasts — browse the full sector.

More AI forecasts

UTHRINCYBIIBBCRXMRNASRPTPRTAAMGNRXRXREGNDNAJAZZEDITNTLA

Will NBIX reach…?

Will NBIX reach $200.00?Will NBIX reach $250.00?Will NBIX reach $500.00?Will NBIX reach $1,000?

Or see the full NBIX price prediction (2027–2040), or the forecast for today, tomorrow and this week.

Compare NBIX

NBIX vs UTHRNBIX vs INCYNBIX vs BIIBNBIX vs BCRXNBIX vs MRNANBIX vs SRPT

Curious how this is generated? Read how K3vl4r forecasts — the model, the confidence bands, and what we deliberately do not claim.

K3vl4r publishes a public, auditable track record of its Daily Top Picks — see the live results.

Forecasts are model-generated estimates for informational purposes only and are not financial advice. Markets are risky; past accuracy does not guarantee future results. See our Risk Disclosure.

k3vl4rTop PicksTrack recordToday's outlookMarket heatmapForecasts by sectorAI reportsCompareMethodologyBest AI toolsAboutFAQ◈ KVLHow KVL worksTokenomicsX (Twitter)Twitch — live forecastingDiscord community

Join the community on Discord and catch live forecasting on Twitch. Create a free account →

Informational only, not financial advice. See Terms, Risk Disclosure, Privacy · Status.